Boehringer and Click's CT-155 plus antipsychotics significantly reduced negative symptoms associated with schizophrenia in a Phase III trial ...

Zimmer has lifted its 2025 outlook due to growth in its sports medicine, extremities, trauma, craniomaxillofacial and thoracic business.

Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to the company, when a pregnant individual is found to carry a ...

The leading site for news and procurement in the medical device industry ...

HistoSonics has announced a majority stake acquisition by a consortium involving a transaction that values the company at $2.25bn.

China's NMPA has approved Bracco Imaging's ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles.

EpiPen patent expiry opens new era for innovation The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery ...

Zimmer Biomet has lifted its 2025 profit outlook to between 6.7% and 7.7%, up from 5.7% to 8.2%, driven by strong growth in its sports medicine, extremities, trauma, craniomaxillofacial and thoracic ...